Chris Moore
Overview
Explore the profile of Chris Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1012
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Munro R, Payne A, Payne A, Holmes N, Moore C, Cahyani I, et al.
Genome Res
. 2025 Jan;
PMID: 39884748
A unique feature of Oxford Nanopore Technologies sequencers, adaptive sampling, allows precise DNA molecule selection from sequencing libraries. Here, we present enhancements to our tool, readfish, enabling all features for...
2.
Hughes J, Sampson F, Sampson F, Buykx P, Long J, Edwards A, et al.
Prehosp Emerg Care
. 2024 Dec;
1-9.
PMID: 39700049
Objectives: Take home naloxone kits can reduce mortality, but we know little about how they are perceived by people with lived experience of opioid use. Provision of naloxone in the...
3.
Bruins W, Rentenaar R, Newcomb J, Zheng W, Ruiter R, Baardemans T, et al.
Hemasphere
. 2024 Nov;
8(11):e70039.
PMID: 39544624
Despite significant progress in the treatment of multiple myeloma (MM), relapsed/refractory patients urgently require more effective therapies. We here describe the discovery, mechanism of action, and preclinical anti-MM activity of...
4.
Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H, et al.
Health Technol Assess
. 2024 Nov;
28(74):1-69.
PMID: 39487686
Background: Opioids kill more people than any other drug. Naloxone is an opioid antagonist which can be distributed in take-home 'kits' for peer administration (take-home naloxone). Aim: To determine the...
5.
Cole M, Anastasiou P, Lee C, Yu X, de Castro A, Roelink J, et al.
Sci Adv
. 2024 Nov;
10(44):eadl6464.
PMID: 39485838
Kirsten rat sarcoma virus (KRAS)-G12C inhibition causes remodeling of the lung tumor immune microenvironment and synergistic responses to anti-PD-1 treatment, but only in T cell infiltrated tumors. To investigate mechanisms...
6.
Watkins A, Jones J, Ali K, Dewar R, Edwards A, Evans B, et al.
Emerg Med J
. 2024 Oct;
41(12):710-716.
PMID: 39389754
Background: Early assessment of patients with suspected transient ischaemic attack (TIA) is crucial to provision of effective care, including initiation of preventive therapies and identification of stroke mimics. Many patients...
7.
Ettinger J, Patel A, Ohrnberger J, Moore C, Bhudiya M, Smith W
BMJ Open Respir Res
. 2024 Oct;
11(1).
PMID: 39384337
Introduction: Treatment options for chronic obstructive pulmonary disease (COPD) are numerous but adherence remains a key challenge. We performed a discrete choice experiment (DCE) of patients' preferences in accessing care...
8.
Bray S, Hamala T, Zhou M, Busoms S, Fischer S, Desjardins S, et al.
Cell Rep
. 2024 Aug;
43(8):114576.
PMID: 39116207
Whole-genome duplication (WGD) occurs in all kingdoms and impacts speciation, domestication, and cancer outcome. However, doubled DNA management can be challenging for nascent polyploids. The study of within-species polyploidy (autopolyploidy)...
9.
Sampson F, Hughes J, Long J, Buykx P, Goodacre S, Snooks H, et al.
BMC Emerg Med
. 2024 Apr;
24(1):75.
PMID: 38679713
Objective: Distribution of take-home naloxone (THN) by emergency services may increase access to THN and reduce deaths and morbidity from opioid overdose. As part of a feasibility study for a...
10.
Corbit J, MacDougall H, Hartlin S, Moore C
Dev Psychol
. 2024 Mar;
60(7):1227-1236.
PMID: 38546569
Collaboration is an early emerging component of successful cooperative relations that produces a cascade of positive social preferences between collaborators. Concurrently, robust preferences for affiliated others may restrict these benefits...